Oncodia specializes in precision medicine in cancer, using innovative methods for fully automated extraction of DNA / RNA and software for analysis of clinically relevant mutations.
We believe that fast and robust analysis methods in combination with reliable results are crucial for being able to implement precision medicine in clinics. Only then can we improve the survival of cancer patients and reduce the costs to society in our joint struggle to fight cancer.
Oncodia develops and sells CE / IVD-labeled, automated extraction methods as well as software for analyzing sequencing data with fast performance and high precision to facilitate and guide the choice of the right cancer therapy. Our vision is a world where every cancer patient should receive the right treatment and prerequisites to fight their disease, and our task is to develop the tools required.
Major investments are currently being made in precision medicine, both in Sweden and in the rest of the world, and we at Oncodia are determined to be a part of it. With a strong team, unique and innovative products and a committed Board, we see a bright future, where no cancer patient is left behind.
